Jane Street’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,600
Closed -$475K 11553
2025
Q1
$475K Buy
3,600
+500
+16% +$62.3K ﹤0.01% 6965
2024
Q4
$259K Sell
3,100
-10,000
-76% -$822K ﹤0.01% 7970
2024
Q3
$959K Sell
13,100
-5,100
-28% -$383K ﹤0.01% 5982
2024
Q2
$1.25M Sell
18,200
-19,200
-51% -$1.33M ﹤0.01% 5355
2024
Q1
$2.59M Buy
37,400
+20,000
+115% +$1.37M ﹤0.01% 3660
2023
Q4
$1.25M Buy
+17,400
New +$1M ﹤0.01% 5165
2023
Q2
Sell
-14,400
Closed -$780K 9779
2023
Q1
$780K Sell
14,400
-91,800
-86% -$4.44M ﹤0.01% 5490
2022
Q4
$5.62M Sell
106,200
-13,600
-11% -$682K 0.01% 2325
2022
Q3
$5.57M Buy
119,800
+500
+0.4% +$26.1K 0.01% 2435
2022
Q2
$6.81M Buy
119,300
+83,900
+237% +$4.76M 0.01% 2219
2022
Q1
$2.17M Sell
35,400
-3,300
-9% -$171K ﹤0.01% 4598
2021
Q4
$2.03M Buy
38,700
+31,900
+469% +$1.34M ﹤0.01% 4468
2021
Q3
$254K Sell
6,800
-12,100
-64% -$421K ﹤0.01% 8482
2021
Q2
$771K Buy
18,900
+4,500
+31% +$166K ﹤0.01% 6392
2021
Q1
$489K Sell
14,400
-33,400
-70% -$1.16M ﹤0.01% 6846
2020
Q4
$1.52M Sell
47,800
-52,000
-52% -$1.37M ﹤0.01% 3991
2020
Q3
$2.56M Sell
99,800
-160,100
-62% -$3.65M 0.01% 2665
2020
Q2
$6.67M Buy
259,900
+244,000
+1,535% +$4.94M 0.03% 1528
2020
Q1
$244K Sell
15,900
-135,100
-89% -$2.93M ﹤0.01% 4447
2019
Q4
$5.18M Buy
+151,000
New +$1.81M 0.03% 1065
2016
Q4
Sell
-39,100
Closed -$596K 4800
2016
Q3
$596K Buy
+39,100
New +$1.58M 0.01% 2574

Other funds holding ITCI